Device and methods of using device for detection of hyperammonemia

Patent metadata

Field	Value
Publication number	US-10620187-B2
Application number	US-201815933834-A
Country	US
Kind code	B2
Filing date	Mar 23, 2018
Priority date	Aug 30, 2013
Publication date	Apr 14, 2020
Grant date	Apr 14, 2020

Abstract

The present disclosure relates to a biosensor capable of measuring the total concentration of one or a plurality of ammonia or ammonium ions with the use of indophenol reagents in the presence of an ionomer. In some embodiments, the biosensor comprises a perfluorinated membrane that comprises an ionomer in contact with an alkali buffer in a vessel configured to receive a sample, such as whole blood. The disclosure also relates to a method of detecting or quantifying the ammonia or ammonium ion concentration in whole blood in a point of care bio sensor without reliance on gas chromatography or any measurement that takes more than about twenty minutes.

First claim

The scope of the present disclosure is not intended to be limited to the above description, but rather is as set forth in the following claims:

1. A method of quantifying a concentration of ammonia or ammonium ion in a sample comprising contacting a sample of bodily fluid to a biosensor, wherein the biosensor comprises:
(i) at least a first and second vessel;
(ii) a fluid exchange opening positioned between the first and the second vessel;
(iii) at least one conduit in fluid communication with the at least first vessel, the at least one conduit configured to receive a fluid from a point external to the biosensor; and
(iv) a membrane positioned at the fluid exchange opening;
wherein the membrane comprises an ionomer;
wherein the at least one conduit is configured to hold a sample volume from about 5 μl to about 100 μl; and
wherein the first vessel or the second vessel comprises, individually or in combination: a hypohalite, an alkali buffer, and at least one phenolic reagent or indophenol related compound;
wherein the sample is in contact with the biosensor for a sufficient period of time to allow modification of the phenolic reagent or indophenol related compound to become modified into a phenolic or indophenol reaction product.

2. The method of claim 1 , wherein the method does not comprise exposing the sample of bodily fluid to any external stimuli or reagent prior to contacting the sample to the biosensor.

3. The method of claim 1 , wherein the sample of bodily fluid is whole blood from a subject.

4. The method of claim 1 , further comprising comparing a concentration value obtained by the contacting step to a threshold value associated with one or more metabolic diseases.

5. The method of claim 4 , wherein the metabolic disease is hyperammonemia.

Assignees

• Univ Maryland
• Childrens Nat Medical Ct
• Us Health

Inventors

• Ayyub Omar Bilal
• Behrens Adam Michael
• Kofinas Peter
• Summar Marshall Lynn
• Cabrera-Luque Juan Manuel
• Cunningham Gary
• Simeonov Anton
• MARUGAN Juan

Classifications

• G01N33/84 Primary

  involving inorganic compounds or pH · CPC title

• G01N2800/04

  Endocrine or metabolic disorders · CPC title

• G01J3/28

  Investigating the spectrum (using colour filters G01J3/51) · CPC title

• G01N33/4925 Primary

  measuring blood gas content, e.g. O2, CO2 , HCO3 · CPC title

• G01N27/327

  Biochemical electrodes {, e.g. electrical or mechanical details for in vitro measurements} · CPC title